1. Home
  2. LVO vs TVGN Comparison

LVO vs TVGN Comparison

Compare LVO & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveOne Inc.

LVO

LiveOne Inc.

HOLD

Current Price

$4.44

Market Cap

56.2M

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$7.38

Market Cap

63.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LVO
TVGN
Founded
2009
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.2M
63.9M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
LVO
TVGN
Price
$4.44
$7.38
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$11.50
N/A
AVG Volume (30 Days)
76.3K
25.0K
Earning Date
02-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
78.57
N/A
EPS
N/A
N/A
Revenue
$114,405,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$0.14
52 Week High
$6.04
$10.76

Technical Indicators

Market Signals
Indicator
LVO
TVGN
Relative Strength Index (RSI) 42.33 76.07
Support Level $3.95 $0.47
Resistance Level $5.55 $10.76
Average True Range (ATR) 0.36 0.53
MACD -0.05 0.10
Stochastic Oscillator 25.98 100.00

Price Performance

Historical Comparison
LVO
TVGN

About LVO LiveOne Inc.

LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: